Health Condition 1: L408- Other psoriasis
Conditions
Interventions
Intervention1: Group 1: Gomutra Arka: The group 1, comprised of 50 patients will be administered Gomutra Arka orally 10ml twice a day for consecutive 2 months. Follow ups will be recorded monthly upto
Sponsors
KS Girhepunje
Department of Kayachikitsa
Eligibility
Inclusion criteria
Inclusion criteria: i. Patient aged between 20 and 50 years ii. Diagnosed cases of Plaque Psoriasis iii. Patient willing to participate in this trial
Exclusion criteria
Exclusion criteria: i. Patients having age less than 20 yrs. and more than 50 yrs ii. Patients of guttate psoriasis, inverse psoriasis, erythrodermic and pustular psoriasis iii. Complicated cases of psoriasis like psoriatic arthritis and any other such type of complications iv. Severely ill patient with weight loss v. Patients having cardiac disease, renal disease and endocrine disorders will be excluded from the study vi. Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Psoriasis Area Severity Index (PASI) 2. Effect on clinical features (Erythema, Scaling, Induration, Itching, Burning sensation)Timepoint: Before treatment (BT), After one month (F1), After two months (F2)and After three months of treatments (AT) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Gut microbiome analysis from stool culture 2. Complete blood count (CBC) 3. C- Reactive protein (CRP) 4. Erythrocyte sedimentation rate (ESR) 5. Liver function test (LFT) 6. Renal function test (RFT) 7. Lipid profile 8. Random blood sugar level (RBS)Timepoint: Before treatment (BT), After one month (F1), After two months (F2)and After three months of treatments (AT) | — |
Countries
India
Contacts
Public ContactKS Girhepunje
Banaras Hindu University Varansi
Outcome results
None listed